We recently published a list of 12 Stocks with Heavy Insider Buying in 2025. In this article, we are going to take a look at ...
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Stock analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for shares of Biohaven in a research note issued on Tuesday, March 4th. Cantor Fitzgerald analyst C. Duncan now expects that ...
In this article, we will take a detailed look at 12 Stocks with Heavy Insider Buying in 2025.
Highlights,Institutional stakeholders, including Rhumbline Advisers, have expanded their holdings in Camden National.,The ...
Highlights,Institutional firms have modified their holdings in Biohaven Ltd., contributing to shifts in stock ...
NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Royal Bank of Canada restated their outperform rating on shares of Biohaven (NYSE:BHVN – Free Report) in a report published ...
3d
TipRanks on MSNBiotech Alert: Searches spiking for these stocks todayThese names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Biohaven fair value estimate is US$28.35 With US$31.37 ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN
Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd ("Biohaven" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results